Construction of non-polar mutants in Haemophilus influenzae using FLP recombinase technology.
BACKGROUND
Nontypeable Haemophilus influenzae (NTHi) is a gram-negative bacterium that causes otitis media in children as well as other infections of the upper and lower respiratory tract in children and adults. We are employing genetic strategies to identify and characterize virulence determinants in NTHi. NTHi is naturally competent for transformation and thus construction of most mutants by common methodologies is relatively straightforward. However, new methodology was required in order to construct unmarked non-polar mutations in poorly expressed genes whose products are required for transformation. We have adapted the lambda red/FLP-recombinase-mediated strategy used in E. coli for use in NTHi.


RESULTS
A cassette containing a spectinomycin resistance gene and an rpsL gene flanked by FRT sites was constructed. A PCR amplicon containing 50 base pairs of DNA homologous to the 5' and 3' ends of the gene to be disrupted and the cassette was generated, then recombineered into the target NTHi gene, cloned on a plasmid, using the lambda recombination proteins expressed in E. coli DY380. Thus, the gene of interest was replaced by the cassette. The construct was then transformed into a streptomycin resistant NTHi strain and mutants were selected on spectinomycin-containing growth media. A plasmid derived from pLS88 with a temperature sensitive replicon expressing the FLP recombinase gene under the control of the tet operator/repressor was constructed. This plasmid was electroporated into the NTHi mutant at the permissive temperature and FLP expression was induced using anhydrotetracycline. The recombinase recognizes the FRT sites and eliminates the antibiotic cassette by site-specific recombination, creating the unmarked non-polar mutation. The plasmid is cured by growth of cells at the restrictive temperature.


CONCLUSIONS
The products of the genes in the NTHi pilABCD operon are required for type IV pilus biogenesis and have a role in transformation. We demonstrated the utility of our methodology by the construction of a non-polar pilA mutation in NTHi strain 2019 and complementation of the mutation with a plasmid containing the pilA gene. Utilization of this approach allowed us to readily generate unmarked non-polar mutations in NTHi genes.
Tracy
Erin
E
Center for Microbial Pathogenesis in The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. Erin.Tracy@nationwidechildrens.org
Ye
Fang
F
Baker
Beth D
BD
Munson
Robert S
RS
D010582:Bacteriophage lambda / Q000201:enzymology; D004254:DNA Nucleotidyltransferases / Q000235:genetics / Q000378:metabolism*; D029968:Escherichia coli Proteins; D036781:Fimbriae Proteins / Q000235:genetics / Q000378:metabolism; D005818:Genetic Engineering; D006193:Haemophilus influenzae / Q000235:genetics* / Q000378:metabolism; D016296:Mutagenesis; D009154:Mutation; D009876:Operon; D011995:Recombination, Genetic; D000091243:Ribosomal Protein S9; D014169:Transformation, Bacterial; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*
D029968:Escherichia coli Proteins; D000091243:Ribosomal Protein S9; C000717190:RpsI protein, E coli; D014764:Viral Proteins; D036781:Fimbriae Proteins; D004254:DNA Nucleotidyltransferases; C045119:FLP recombinase